Cargando…
Passive immunization against phosphorylated tau improves features of Huntington's disease pathology
Huntington's disease is classically described as a neurodegenerative disorder of monogenic aetiology. The disease is characterized by an abnormal polyglutamine expansion in the huntingtin gene, which drives the toxicity of the mutated form of the protein. However, accumulation of the microtubul...
Autores principales: | Alpaugh, Melanie, Masnata, Maria, de Rus Jacquet, Aurelie, Lepinay, Eva, Denis, Hélèna L., Saint-Pierre, Martine, Davies, Peter, Planel, Emmanuel, Cicchetti, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077324/ https://www.ncbi.nlm.nih.gov/pubmed/35051614 http://dx.doi.org/10.1016/j.ymthe.2022.01.020 |
Ejemplares similares
-
Targeting Tau to Treat Clinical Features of Huntington's Disease
por: Masnata, Maria, et al.
Publicado: (2020) -
Correction to: Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders
por: de Rus Jacquet, Aurélie, et al.
Publicado: (2021) -
Correction: Shedding a new light on Huntington’s disease: how blood can both propagate and ameliorate disease pathology
por: Rieux, Marie, et al.
Publicado: (2020) -
Untangling the Role of Tau in Huntington’s Disease Pathology
por: Salem, Shireen, et al.
Publicado: (2023) -
Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms
por: Masnata, Maria, et al.
Publicado: (2019)